Skip to content

A Validation Study of Nitroglycerin Induced Acute Drop of Pd/Pa (NTG-Pd/Pa) in Clinical Practice

A Validation Study of Nitroglycerin Induced Acute Drop of Pd/Pa (NTG-Pd/Pa) in Clinical Practice

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04700397
Enrollment
100
Registered
2021-01-07
Start date
2021-01-02
Completion date
2024-02-29
Last updated
2021-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension Symptomatic, Ischemic Heart Disease

Keywords

NTG-Pd/Pa, Fractional flow reserve, adenosine

Brief summary

Hyperemia with adenosine was an elemental process in FFR examination. Adenosine injection will induce some discomfort, and increase cost expenditure. Nitroglycerine will induce an acute drop of Pd/Pa, and this lowest Pd/Pa was determined as NTG-Pd/Pa. NTG-Pd/Pa has a linear relationship with FFR value and has a good diagnostic accuracy to predict FFR≤0.80 in our recent study. There is only one prospective study report on the relationship between NTG-Pd/Pa and FFR. In this study, we aim to evaluate the safety of NTG-Pd/Pa, the repeatability and dose-response of this novel index. Furthermore, we will investigate the diagnostic accuracy of NTG-Pd/Pa, with FFR≤0.8 and Resting full-cycle ratio≤0.89 as ischemic threshold respectively.

Detailed description

Fractional flow reserve (FFR) is defined as the ratio of mean distal pressure (distal to the target lesion, Pd)to mean proximal pressure (aortic pressure, Pa) in the coronary artery(Pd/Pa) while the maximal hyperemic flow is achieved. Nowadays, FFR-guided PCI is highly recommended for the assessment of physiologic ischemia in intermediate coronary lesions. However, hyperemia with adenosine was an elemental process in FFR examination. Adenosine injection will induce some discomfort, and increase cost expenditure. Based on the clinical and physiologic outcome study, a lot of non-hyperemic indexes had been proposed, and adenosine injection could be waived. Whereas, these novel physiologic indexes are limited to the proprietary software of each vendor, curtailing clinical application. Intracoronary nitroglycerin injection was needed before each FFR assessment. Nitroglycerine will induce an acute drop of Pd/Pa, and this lowest Pd/Pa was determined as NTG-Pd/Pa. NTG-Pd/Pa has a linear relationship with FFR value and has a good diagnostic accuracy to predict FFR≤0.80 in our recent study. There is only one prospective study report on the relationship between NTG-Pd/Pa and FFR. In this study, we aim to evaluate the safety of NTG-Pd/Pa, the repeatability and dose-response of this novel index. Furthermore, we will investigate the diagnostic accuracy of NTG-Pd/Pa, with FFR≤0.8 and Resting full-cycle ratio≤0.89 as ischemic threshold respectively.

Interventions

DIAGNOSTIC_TESTNitroglycerine

We aim to test the repeatability of NTG-Pd/Pa with different dosages of nitroglycerine injection.

Sponsors

National Taiwan University Hospital Hsin-Chu Branch
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Eligible for FFR examination

Exclusion criteria

* Hypersensitivity to adenosine or nitroglycerine * Severe Valvular aortic stenosis * Resting heart rate less than 50 beats per minutes * Systolic blood pressure less than 100 mmHg or diastolic blood pressure less than 40 mmHg * exposure to PDE-5 inhibitors within 48 hours. * Recent intracranial hemorrhage or brain injury

Design outcomes

Primary

MeasureTime frameDescription
The repeatability and dose response of NTG-Pd/Pa10 minutesComparing the difference of NTG-Pd/Pa value after various dosage of nitroglycerine injection in the same coronary lesion

Secondary

MeasureTime frameDescription
Major adverse cardiac event2 yearsMACE including target lesion failure, target vessel failure, target vessel-related myocardial infarction, and cardiac death
Diagnostic accuracy of NTG-Pd/Pa 130 minutesInvestigate the diagnostic accuracy of NTG-Pd/Pa, with FFR≤0.8 as ischemic threshold
Diagnostic accuracy of NTG-Pd/Pa 230 minutesInvestigate the diagnostic accuracy of NTG-Pd/Pa, with RFR≤0.89 as ischemic threshold

Other

MeasureTime frameDescription
Nitroglycerine related adverse events1 hourIncluding symptomatic hypotension or severe headache

Countries

Taiwan

Contacts

Primary ContactChien-Boon Jong, MD
jgboon0407@gmail.com+88635322140

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026